Comparative efficacy and safety of vonoprazan-based dual therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication: a GRADE-assessed systematic review and meta-analysis with trial sequential analysis.
- DOI
- 10.3389/fmicb.2026.1872669
- Published
- 2026
- Container
- Frontiers in microbiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmicb.2026.1872669,
title = {Comparative efficacy and safety of vonoprazan-based dual therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication: a GRADE-assessed systematic review and meta-analysis with trial sequential analysis.},
author = {Chen Liang A and Cruz Castillo Y and Murrieta Bruciaga LM and Abreu Lopez B and Covarrubias SB and Flores Uribe HJ and Salolin-Vargas VP and Flores Monar G and García-Corella J and Kalha I and Calderon Martinez E},
year = {2026},
journal = {Frontiers in microbiology},
doi = {10.3389/fmicb.2026.1872669},
url = {https://doi.org/10.3389/fmicb.2026.1872669}
}RIS
TY - JOUR TI - Comparative efficacy and safety of vonoprazan-based dual therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication: a GRADE-assessed systematic review and meta-analysis with trial sequential analysis. AU - Chen Liang A AU - Cruz Castillo Y AU - Murrieta Bruciaga LM AU - Abreu Lopez B AU - Covarrubias SB AU - Flores Uribe HJ AU - Salolin-Vargas VP AU - Flores Monar G AU - García-Corella J AU - Kalha I AU - Calderon Martinez E PY - 2026 JO - Frontiers in microbiology DO - 10.3389/fmicb.2026.1872669 UR - https://doi.org/10.3389/fmicb.2026.1872669 ER -
APA
A, C. L., Y, C. C., LM, M. B., B, A. L., SB, C., HJ, F. U., VP, S., G, F. M., J, G., I, K., & E, C. M. (2026). Comparative efficacy and safety of vonoprazan-based dual therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication: a GRADE-assessed systematic review and meta-analysis with trial sequential analysis.. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2026.1872669
Source records
- pubmed · retrieved 2026-09-26T18:17:23.513Z